Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wassim H Fares

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|January 29, 2013
Not all catheter-days are equalWassim H Fares
Critical Care (London, England)|July 17, 2014
The 'availability' bias: underappreciated but with major potential implicationsWassim H Fares
Heart & Lung : the Journal of Critical Care|May 17, 2008
Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?Wassim H Fares
Annals of the American Thoracic Society|May 16, 2014
The other vascular beds in pulmonary arterial hypertension. Surrogates or associated?Wassim H Fares
American Journal of Respiratory and Critical Care Medicine|March 14, 2015
Orenitram . . . not verifiedWassim H Fares
American Journal of Respiratory and Critical Care Medicine|June 16, 2016
Reply: Oral Treprostinil Combination Trials Post Hoc Secondary Analyses: A Step toward Verifying Its EfficacyWassim H Fares
Journal of Cardiovascular Pharmacology|February 18, 2016
Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What Is Reasonable?Wassim H Fares
Cancer|August 29, 2013
Amiodarone and the risk of cancer: a nationwide population-based studyWassim H Fares
Cleveland Clinic Journal of Medicine|June 21, 2006
Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?Wassim H Fares, Ashish Aneja
American Journal of Respiratory Cell and Molecular Biology|April 1, 2017
Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection FractionWassim H Fares, Naftali Kaminski
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|January 29, 2013
Not all catheter-days are equalWassim H Fares
Critical Care (London, England)|July 17, 2014
The 'availability' bias: underappreciated but with major potential implicationsWassim H Fares
Heart & Lung : the Journal of Critical Care|May 17, 2008
Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?Wassim H Fares
Annals of the American Thoracic Society|May 16, 2014
The other vascular beds in pulmonary arterial hypertension. Surrogates or associated?Wassim H Fares
American Journal of Respiratory and Critical Care Medicine|March 14, 2015
Orenitram . . . not verifiedWassim H Fares
American Journal of Respiratory and Critical Care Medicine|June 16, 2016
Reply: Oral Treprostinil Combination Trials Post Hoc Secondary Analyses: A Step toward Verifying Its EfficacyWassim H Fares
Journal of Cardiovascular Pharmacology|February 18, 2016
Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What Is Reasonable?Wassim H Fares
Cancer|August 29, 2013
Amiodarone and the risk of cancer: a nationwide population-based studyWassim H Fares
Cleveland Clinic Journal of Medicine|June 21, 2006
Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?Wassim H Fares, Ashish Aneja
American Journal of Respiratory Cell and Molecular Biology|April 1, 2017
Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection FractionWassim H Fares, Naftali Kaminski
Pageof 6